Dopaminergic Modulation of Immediate Reward Bias

立即奖励偏差的多巴胺能调节

基本信息

  • 批准号:
    8265989
  • 负责人:
  • 金额:
    $ 3.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-05 至 2012-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): For alcohol-dependent individuals who are fortunate enough to become abstinent, 45% to 75% will relapse at least once. One way to potentially decrease the occurrence of relapse is to investigate the neurobiology of behavioral traits that may contribute to relapse. One such trait is the tendency to choose smaller immediate rewards ("Now") over larger delayed rewards ("Later"), which is more common among individuals with a history of alcohol dependence than among those without. This preference for Now versus Later, or immediate reward bias, is thus an intermediate behavioral phenotype for alcohol use disorders. Such intermediate phenotypes are thought to be more amenable to investigation, as they are relatively less complex and are likely to be less etiologically heterogeneous compared to alcohol use disorders. While recent studies have begun to establish the neural circuitry underlying immediate reward bias, the neurobiological mechanisms that contribute to this clinically significant behavioral trait remain to be fully investigated. In addition to alcohol abuse history, a variation in the catechol-O-methyltransferase (COMT) gene predicts both Now versus Later preference and underlying brain activity in the prefrontal and posterior parietal cortex. COMT is an enzyme responsible for the breakdown of dopamine and is the primary regulator of dopamine levels in the cortex. A common functional variation in the COMT gene results in an enzyme with either high or low activity. The COMT genotype that leads to high levels of COMT activity, and therefore low levels of dopamine, is associated with greater immediate reward bias relative to the other two genotypes. These data suggest there is an inverse relationship between baseline cortical dopamine and an individual's preference for Now versus Later. However, it is unknown whether baseline dopamine levels interact with transient fluctuations in dopamine to alter immediate reward bias and underlying brain activity. We predict that transient fluctuations in dopamine will affect immediate reward bias and fronto-parietal activity in a COMT genotype-dependent fashion in both control subjects and alcohol-dependent individuals. We will test this hypothesis with two complementary experiments that entail different transient manipulations of dopamine. In Aim 1, we will acutely deplete dopamine using an amino acid beverage deficient in the precursors required for dopamine synthesis. In Aim 2, we will transiently elevate dopamine by administering a COMT inhibitor. In both studies, participants will complete a Now/Later decision making task during functional magnetic resonance imaging to test whether acute dopaminergic manipulations change immediate reward bias and the underlying brain activity and whether such effects are moderated by COMT genotype or alcohol use history. This is one of the first studies to examine the neurobiological bases of pharmacological manipulation of impulsive decision making. Because immediate reward bias is a characteristic of alcohol-dependent individuals, these results could lead to the development of novel supportive therapies and improved treatment outcomes for people seeking abstinence.
描述(由申请人提供):对于幸运地戒酒的酒精依赖者,45%至75%的人至少会复发一次。一种可能减少复发发生的方法是研究可能导致复发的行为特征的神经生物学。其中一个特征是倾向于选择较小的即时奖励(“现在”)而不是较大的延迟奖励(“以后”),这在有酒精依赖史的人中比那些没有酒精依赖史的人更常见。因此,这种对现在与以后的偏好,或立即奖励偏见,是酒精使用障碍的中间行为表型。这种中间表型被认为更适合调查,因为它们相对不那么复杂,并且与酒精使用障碍相比,可能在病因学上不那么异质。虽然最近的研究已经开始建立神经回路的基础立即奖励偏见,神经生物学机制,有助于这一临床上显着的行为特征仍有待充分调查。除了酒精滥用史,儿茶酚-O-甲基转移酶(COMT)基因的变异预测了现在与以后的偏好以及前额叶和后顶叶皮层的潜在大脑活动。COMT是一种负责多巴胺分解的酶,是大脑皮层多巴胺水平的主要调节因子。COMT基因中常见的功能变异导致酶具有高或低活性。COMT基因型导致高水平的COMT活性,因此多巴胺水平较低,与其他两种基因型相比,与更大的即时奖励偏差相关。这些数据表明,基线皮质多巴胺和个体对现在与以后的偏好之间存在反比关系。然而,目前尚不清楚基线多巴胺水平是否与多巴胺的瞬时波动相互作用,以改变即时奖励偏见和潜在的大脑活动。我们预测,在对照受试者和酒精依赖个体中,多巴胺的短暂波动将以COMT基因型依赖的方式影响立即奖励偏差和额顶叶活动。我们将通过两个补充实验来验证这一假设,这两个实验需要对多巴胺进行不同的瞬时操作。在目标1中,我们将使用缺乏多巴胺合成所需前体的氨基酸饮料来急剧消耗多巴胺。在目标2中,我们将通过给予COMT抑制剂短暂升高多巴胺。在这两项研究中,参与者将在功能性磁共振成像期间完成现在/以后的决策任务,以测试急性多巴胺能操纵是否会改变立即奖励偏见和潜在的大脑活动,以及这种影响是否会受到COMT基因型或酒精使用史的调节。这是第一个研究检查冲动决策的药理学操纵的神经生物学基础。由于即时奖励偏见是酒精依赖者的一个特征,这些结果可能会导致开发新的支持性疗法,并改善寻求戒酒者的治疗效果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary K Kelm其他文献

Mary K Kelm的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary K Kelm', 18)}}的其他基金

Dopaminergic Modulation of Immediate Reward Bias
立即奖励偏差的多巴胺能调节
  • 批准号:
    8121135
  • 财政年份:
    2011
  • 资助金额:
    $ 3.69万
  • 项目类别:
The Role of IP3 and Ryanodine Receptors in Ethanol-enhanced GABA Release
IP3 和 Ryanodine 受体在乙醇增强 GABA 释放中的作用
  • 批准号:
    7331000
  • 财政年份:
    2007
  • 资助金额:
    $ 3.69万
  • 项目类别:
The Role of IP3 and Ryanodine Receptors in Ethanol-enhanced GABA Release
IP3 和 Ryanodine 受体在乙醇增强 GABA 释放中的作用
  • 批准号:
    7509516
  • 财政年份:
    2007
  • 资助金额:
    $ 3.69万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 3.69万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了